Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma.

Abstract:

:During the initiation and progression of malignant melanoma a series of genetic events accumulate, including alterations of chromosome 11q. Recently, an important tumour suppressor gene, the multiple endocrine neoplasia type 1 (MEN1) gene, has been mapped on 11q13 and has been cloned. To assess whether the MEN1 region is involved in tumour initiation and progression, we analysed 23 primary cutaneous melanomas and 17 metastases for loss of heterozygosity (LOH) using two informative polymorphic markers closely linked to the MEN1 gene (PYGM and D11S449). To search for mutations within the gene, single-strand conformation polymorphism (SSCP) analysis was performed using 13 primer sets with designed intronic sequences to amplify the MEN1 coding sequence exons 2 to 10. None of the cases showed LOH at the MEN1 gene locus. By SSCP analysis, no aberrant bands were identified on exons 3 to 10. Analysis of exon 2 revealed the presence of aberrant bands in two of the analysed melanomas. Sequencing analysis revealed a genetic polymorphism at S145S (AGC-->ACT) in both sections. None of the cases analysed showed MEN1 gene mutations. This study represents the first genetic analysis of the MEN1 gene in sporadic melanomas. Our data demonstrate no evidence of deletion or mutation of the MEN1 gene in primary or metastatic melanoma. Therefore, MEN1 gene alterations appear not to be associated with tumorigenesis of malignant melanoma. The MEN1 gene appears to be a highly specific tumour suppressor gene only involving tumours within the spectrum of MEN1 disease.

journal_name

Melanoma Res

journal_title

Melanoma research

authors

Böni R,Vortmeyer AO,Huang S,Burg G,Hofbauer G,Zhuang Z

doi

10.1097/00008390-199906000-00006

subject

Has Abstract

pub_date

1999-06-01 00:00:00

pages

249-52

issue

3

eissn

0960-8931

issn

1473-5636

journal_volume

9

pub_type

杂志文章
  • Life-threatening polymyositis with spontaneous hematoma induced by nivolumab in a patient with previously resected melanoma.

    abstract::Single-agent anti-PD1 antibodies are usually very well tolerated, but serious toxicity can still occur. Despite the PD-1 pathway seems to be relevant in the pathogenesis of immune-related myositis, anti-PD1-related myositis is generally a rare side effect of the treatment and usually not serious. However, its frequenc...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000706

    authors: Liu WK,Naban N,Kaul A,Patel N,Fusi A

    更新日期:2021-02-01 00:00:00

  • Molecular alterations associated with acquired resistance to BRAFV600E targeted therapy in melanoma cells.

    abstract::Selective inhibition of the mutant BRAF protein is a highly promising therapeutic approach for melanoma patients carrying the BRAF mutation. Despite the remarkable clinical response, most patients develop resistance and experience tumour regrowth. To clarify the molecular background of BRAF inhibitor resistance, we ge...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000588

    authors: Szász I,Koroknai V,Kiss T,Vízkeleti L,Ádány R,Balázs M

    更新日期:2019-08-01 00:00:00

  • Frequency of colour vision deficiencies in melanoma patients: results of a prospective comparative screening study with the Farnsworth panel D 15 test including 300 melanoma patients and 100 healthy controls.

    abstract::Patients with melanoma may experience a variety of different vision symptoms, in part associated with melanoma-associated retinopathy. For several melanoma patients with or without melanoma-associated retinopathy, colour vision deficiencies, especially involving the tritan system, have been reported. The frequency of ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/01.cmr.0000222599.35062.84

    authors: Pföhler C,Tschöp S,König J,Rass K,Tilgen W

    更新日期:2006-10-01 00:00:00

  • Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program.

    abstract::Ipilimumab, a fully human, recombinant, monoclonal antibody to cytotoxic T-lymphocyte antigen 4 improves overall survival (OS) in previously treated and untreated metastatic melanoma. This retrospective analysis reports data gathered by a questionnaire on the demographics, outcomes, and toxicity of ipilimumab administ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000108

    authors: Berrocal A,Arance A,Lopez Martin JA,Soriano V,Muñoz E,Alonso L,Espinosa E,Lopez Criado P,Valdivia J,Martin Algarra S,Spanish Melanoma Group.

    更新日期:2014-12-01 00:00:00

  • Statistical evaluation of epiluminescence microscopy criteria in the differential diagnosis of malignant melanoma and pigmented basal cell carcinoma.

    abstract::Pigmented basal cell carcinoma (PBCC) is a tumour with distinct clinical features which occasionally may be difficult to differentiate from malignant melanoma (MM). The purpose of this study was to re-examine the epiluminescence microscopy (ELM) criteria for PBCC and to determine their statistical significance in the ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199708000-00005

    authors: Püspök-Schwarz M,Steiner A,Binder M,Partsch B,Wolff K,Pehamberger H

    更新日期:1997-08-01 00:00:00

  • Redox regulation of Brn-2/N-Oct-3 POU domain DNA binding activity and proteolytic formation of N-Oct-5 during melanoma cell nuclear extraction.

    abstract::Reversible oxidation sensitivity of N-Oct-3 DNA binding activity was seen when melanoma extracts and recombinant Brn-2 protein were treated with a variety of metals, hydrogen peroxide and the cysteine disulphide bond forming agent diamide. Western blot analysis of diamide-oxidized N-Oct-3 protein indicated that this w...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199802000-00002

    authors: Smith AG,Brightwell G,Smit SE,Parsons PG,Sturm RA

    更新日期:1998-02-01 00:00:00

  • Cytotoxic effects of violacein in human uveal melanoma cell lines.

    abstract::Violacein is the main pigment produced by Chromobacterium violaceum, a saprophytic gram-negative bacillus. Violacein is formed by the condensation of two modified tryptophan molecules and has potential anti-neoplastic effects. The purpose of this pilot study was to investigate the in vitro activity of violacein in hum...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200410000-00014

    authors: Saraiva VS,Marshall JC,Cools-Lartigue J,Burnier MN Jr

    更新日期:2004-10-01 00:00:00

  • Primary malignant melanoma of the urinary bladder: clinical, morphological, and molecular analysis of five cases.

    abstract::The aim of our study was to evaluate the clinical and morphological features of primary malignant melanomas of the urinary bladder. We obtained information on five such cases from three different institutions. These were three men and two women between 52 and 76 years of age. Three tumors presented with hematuria, one...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000300

    authors: Karabulut YY,Erdogan S,Sayar H,Ergen A,Ertoy Baydar D

    更新日期:2016-12-01 00:00:00

  • Serum zinc levels are increased in melanoma patients.

    abstract::We studied the levels of serum copper and zinc as possible diagnostic factors or markers for the early detection of patients with melanoma. Levels were determined in 35 melanoma patients at various clinical stages and in 39 healthy persons. Measurements were performed by atomic absorption spectroscopy using 5100-PC-Pe...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:

    authors: Ros-Bullón MR,Sánchez-Pedreño P,Martínez-Liarte JH

    更新日期:1998-06-01 00:00:00

  • Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth.

    abstract::Melanoma tumors have been shown to comprise both invasive and proliferative cell subpopulations. These populations are highly plastic, thus hampering full characterization and therapeutic targeting of dormant and partially dedifferentiated invasive cells. We have reported, previously, that melanoma cells grown in a se...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e328351e7c4

    authors: Ghislin S,Deshayes F,Lauriol J,Middendorp S,Martins I,Al-Daccak R,Alcaide-Loridan C

    更新日期:2012-06-01 00:00:00

  • Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-beta.

    abstract::Tumor cell invasion through basement membranes and into stromal tissue are key steps for promoting growth and metastasis. Tumor cells express various extracellular-matrix-degrading enzymes such as matrix metalloproteinases (MMPs) to degrade extracellular matrix components to facilitate tumor migration and invasion. Hi...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e3282a660ad

    authors: Iida J,McCarthy JB

    更新日期:2007-08-01 00:00:00

  • Sentinel node localization in primary melanoma: learning curve and results.

    abstract::Ninety primary melanoma patients were studied to investigate the importance of adopting the simultaneous use of patent blue dye (PBD) and lymphoscintigraphy plus gamma detection probe to locate the sentinel node (SN). In total 135 SNs in 105 basins were visualized preoperatively under a gamma camera after lymphoscinti...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199912000-00008

    authors: Testori A,Bartolomei M,Grana C,Mezzetti M,Chinol M,Mazzarol G,Lazzari I,Paganelli G,Geraghty JG,Andreoni B,Veronesi U

    更新日期:1999-12-01 00:00:00

  • Serum melatonin levels in melanoma patients after repeated oral administration.

    abstract::The goal of this study was to determine the effect of oral melatonin in divided doses on plasma melatonin levels in patients with metastatic melanoma. Hourly blood samples were obtained from five patients for 24 h prior to melatonin administration and for 24 h during oral administration of melatonin, 50 mg every 4 h. ...

    journal_title:Melanoma research

    pub_type: 临床试验,杂志文章

    doi:10.1097/00008390-199402000-00009

    authors: Kane MA,Johnson A,Nash AE,Boose D,Mathai G,Balmer C,Yohn JJ,Robinson WA

    更新日期:1994-02-01 00:00:00

  • Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case-control study in Belgium, France and Germany. The EORTC Malig

    abstract::This study addressed the impact of exposure to ultraviolet radiation on the risk of cutaneous malignant melanoma (CMM), as well as the behavioral components at stake in its occurrence. We performed a one-to-one unmatched case-control study among subjects aged 20 years or more with naturally non-pigmented skin in Germa...

    journal_title:Melanoma research

    pub_type: 杂志文章,多中心研究

    doi:10.1097/00008390-199404000-00001

    authors: Autier P,Doré JF,Lejeune F,Koelmel KF,Geffeler O,Hille P,Cesarini JP,Liénard D,Liabeuf A,Joarlette M

    更新日期:1994-04-01 00:00:00

  • Quality of life patient-reported outcomes for locally advanced cutaneous melanoma.

    abstract::Locally advanced cutaneous melanoma has marked quality-of-life implications; however, the patient experience of symptom management and subsequent impact on quality of life has not been well described. This study aims to address the impact on patients of advanced cutaneous melanoma through qualitative interviews. Adult...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000425

    authors: Weitman ES,Perez M,Thompson JF,Andtbacka RHI,Dalton J,Martin ML,Miller T,Gwaltney C,Sarson D,Wachter E,Zager JS

    更新日期:2018-04-01 00:00:00

  • Coordinated mRNA expression of c-Kit with tyrosinase and TRP-1 in melanin pigmentation of normal and malignant human melanocytes and transient activation of tyrosinase by Kit/SCF-R.

    abstract::The proto-oncogene c-Kit encodes a membrane receptor protein with intrinsic tyrosine kinase activity. Activation of c-Kit induces cell proliferation, differentiation or migration among different cell types. The present study provides evidence that c-Kit plays an important role in the cell differentiation rather than i...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199510000-00002

    authors: Luo D,Chen H,Searles G,Jimbow K

    更新日期:1995-10-01 00:00:00

  • Inactive cathepsin B-like enzyme in human melanoma culture medium.

    abstract::An inactive cathepsin B-like enzyme with a molecular mass of 40 kD was found in a human melanoma culture medium. The inactive form of this enzyme was converted into an active form with a molecular mass of 28 kD by pepsin treatment. This activated cathepsin B-like enzyme had almost the same characteristics regarding mo...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199201000-00005

    authors: Tsushima H,Hyodoh F,Yoshida E,Ueki A,Hopsu-Havu VK

    更新日期:1992-01-01 00:00:00

  • Risk of cutaneous melanoma in a cohort of infertile women.

    abstract::We assessed the risk of cutaneous malignant melanoma associated with the presence of ovulatory abnormalities and with the use of ovulation-inducing agents (such as clomiphene citrate) in a cohort of 3,837 women evaluated at infertility clinics in Seattle, WA, between 1974 and 1985. Computer linkage with a population-b...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199504000-00009

    authors: Rossing MA,Daling JR,Weiss NS,Moore DE,Self SG

    更新日期:1995-04-01 00:00:00

  • Clinical significance of serum M30 and M65 levels in melanoma.

    abstract::M30 and M65 are relatively new assays that detect different circulating forms of the epithelial cell structural protein cytokeratin 18. This study was carried out to investigate the serum levels of M30 and M65 in patients with melanoma and the relationship with tumor progression and known prognostic parameters. Fifty-...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e328363e4ab

    authors: Tas F,Karabulut S,Serilmez M,Yildiz I,Sen F,Ciftci R,Duranyildiz D

    更新日期:2013-10-01 00:00:00

  • Rising melanoma incidence in an Italian community from 1986 to 1997.

    abstract::We examined the incidence of primary invasive melanoma in the municipality of Reggio Emilia, northern Italy, in the period from 1986 to 1997. We identified 169 cases, five of which were intraocular. After adjustment for confounders, the risk of having a thick melanoma (Breslow > or = 1 mm) did not decrease over time, ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199902000-00013

    authors: Vinceti M,Bergomi M,Borciani N,Serra L,Vivoli G

    更新日期:1999-02-01 00:00:00

  • Defect of insulin receptor in insulin-resistant variants of Cloudman S91 mouse melanoma cells.

    abstract::To study the mechanisms by which insulin regulates proliferation, we have compared wild-type Cloudman melanoma cells, whose growth in inhibited by insulin (insinh) to variant lines that were genetically selected for resistance to insulin (insres). Scatchard analysis of insulin binding to five insres) lines and six ins...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-199207000-00006

    authors: Slominski A,McNeely T,Pawelek J

    更新日期:1992-07-01 00:00:00

  • Malignant melanoma: relationship to parameters of differentiation.

    abstract::Malignant melanoma is not only one of the most aggressive and lethal types of neoplasm, but its incidence in the general population is currently increasing at an alarming pace. It is interesting that most melanomas retain many of their characteristics of differentiation, including a dendritic nature and the production...

    journal_title:Melanoma research

    pub_type: 杂志文章,评审

    doi:

    authors: Tsukamoto K,Gersten DM,Law LW,Hearing VJ

    更新日期:1991-11-01 00:00:00

  • Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients.

    abstract::High-dose cisplatin regimens have been shown to be highly active in advanced melanoma patients but are associated with unacceptable side effects. In order to increase the platinum dose but avoid severe side effects, we treated 15 dacarbazine (DTIC)-resistant metastatic melanoma patients with a combination regimen of c...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/00008390-200108000-00012

    authors: Güven K,Kittler H,Wolff K,Pehamberger H

    更新日期:2001-08-01 00:00:00

  • Evaluating the usefulness of self-reported risk factors in a skin cancer screening program.

    abstract::The objective of this study was to describe the risk factor profile of skin cancer screening participants and to determine whether there is an association between the number of skin cancer/melanoma risk factors and the likelihood of diagnosis of a malignant melanoma. Seventy skin cancer screening clinics were held by ...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/01.cmr.0000205023.02527.ab

    authors: Williams HA,Fritschi L,Beauchamp C,Katris P

    更新日期:2006-08-01 00:00:00

  • Metformin: oxidative and proliferative parameters in-vitro and in-vivo models of murine melanoma.

    abstract::Cutaneous melanoma is one of the most lethal cancers because of its increased rate of metastasis and resistance to available therapeutic options. Early studies indicate that metformin has beneficial effects on some types of cancer, including melanoma. To clarify knowledge of the mechanism of action of metformin on thi...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000391

    authors: de Souza Neto FP,Bernardes SS,Marinello PC,Melo GP,Luiz RC,Cecchini R,Cecchini AL

    更新日期:2017-12-01 00:00:00

  • A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme.

    abstract::We studied the efficacy, tolerability and clinical courses of dabrafenib in patients with metastatic melanoma who were ineligible for enrolment into a clinical trial. Between July 2011 and May 2013, patients with unresectable stage III or stage IV, V600-mutated metastatic melanoma who were not eligible for inclusion i...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000036

    authors: Lau DK,Andrews MC,Turner N,Azad AA,Davis ID,Cebon JS

    更新日期:2014-04-01 00:00:00

  • Comparison of eumelanin and pheomelanin content between cultured uveal melanoma cells and normal uveal melanocytes.

    abstract::Levels of eumelanin (EM) and pheomelanin (PM) of uveal melanoma cells have not been measured and compared with those of normal uveal melanocytes. EM and PM amounts in four immortal human uveal melanoma cell lines were measured by chemical degradation and microanalytical high-performance liquid chromatography and compa...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e328329ae49

    authors: Hu DN,Wakamatsu K,Ito S,McCormick SA

    更新日期:2009-04-01 00:00:00

  • The transcription factor CUTL1 is associated with proliferation and prognosis in malignant melanoma.

    abstract::The transcription factor CUTL1 (CCAAT displacement protein 1) has been reported to participate in the proliferation of diverse types of cancer. In the present study, we investigated the potential involvement of CUTL1 in the proliferation of malignant melanoma. We found that CUTL1 expression was upregulated in malignan...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000064

    authors: Fan X,Wang H,Zhou J,Wang S,Zhang X,Li T,Nie Y,Liu B

    更新日期:2014-06-01 00:00:00

  • PD-1/PD-L1 and VEGF-A/VEGF-C expression in lymph node microenvironment and association with melanoma metastasis and survival.

    abstract::Regional lymph nodes are affected frequently by melanoma metastasis. Its microenvironment may be associated with tumor progression. We investigated sentinel nodes with and without tumor and negative nodes surrounding positive nodes, looking for patterns related to tumor immune interaction and lymphovascular progressio...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0000000000000396

    authors: Alessi C,Scapulatempo Neto C,Viana CR,Vazquez VL

    更新日期:2017-12-01 00:00:00

  • Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.

    abstract::Recently, we reported on the associations of seven single nucleotide polymorphisms (SNPs) in the promoter region of MMP1 gene with susceptibility to cutaneous melanoma (CM). Considering the reported correlation between MMP1 expression and melanoma progression, we hypothesized that these promoter SNPs might affect CM p...

    journal_title:Melanoma research

    pub_type: 杂志文章

    doi:10.1097/CMR.0b013e32834fc46b

    authors: Liu H,Wei Q,Gershenwald JE,Prieto VG,Lee JE,Duvic M,Grimm EA,Wang LE

    更新日期:2012-04-01 00:00:00